Clarient has launched a new gene mutation test to help physicians select the appropriate therapy for non-small cell lung cancer.
Burrill Report: Financing Activity May Lift Cloud Hanging Over Biotech Industry
While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be lifting a little.
Provenge Extends Life of Prostate Cancer Patients, Study Finds
Researchers found that Dendreon’s immunotherapy drug Provenge prolonged the lives of advanced prostate cancer patients by an average of 4.1 months compared to a placebo.
An engineering approach to translational medicine
The mechanisms that drive disease have long confounded the medical industry. How much of a part does genetics play? How does the patient’s lifestyle influence his or her risk of developing cancer? What makes one patient respond favorably to a particular treatment, while another suffers severe side effects?
OneMedForum 2009: Panels and Speakers
The OneMedPlace finance conference for emerging med tech companies, the OneMedForum, will be held January 13-14 in San Francisco. Click here to learn more. Our featured panelists and speakers will be recognized […]
Breast MRI Up 23% in First Half of 2008
Magnetic resonance imaging (MRI) of the breast continues to show double digit growth in 2008 and is one of the fastest growing procedures in radiology departments, this according to Arlington Medical Resources […]
[AdvaMed 2008] Video Roundup
Our in-house dynamo, Claudia Pinzon and the rest of the the talented team at OneMedTV, have been busy compiling a wealth of valuable video content captured at AdvaMed2008. Below, some of that […]
